Causality of Blood Metabolites on Proliferative Diabetic Retinopathy: Insights From a Genetic Perspective
Conclusion: These metabolites have the potential to be used as biomarkers and are promising for future research into the mechanisms and drug targets for PDR.
Saved in:
Main Authors: | Zhaoxiang Wang, Bing Lu, Li Zhang, Yuwen Xia, Xiaoping Shao, Shao Zhong |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2024/6828908 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proliferative Diabetic Retinopathy and Hemovitreous: Red Flag for Blindness
by: Jaume Català, et al.
Published: (2008-01-01) -
Searching for Biomarkers in Proliferative Diabetic Retinopathy: Amphiregulin and Progranulin
by: Burak BILGIN, et al.
Published: (2022-12-01) -
Human Genetics of Diabetic Retinopathy: Current Perspectives
by: Daniel P. K. Ng
Published: (2010-01-01) -
Change of Vascular Endothelial Growth Factor Levels following Vitrectomy in Eyes with Proliferative Diabetic Retinopathy
by: Hui-Jin Chen, et al.
Published: (2019-01-01) -
Causes and Clinical Impact of Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy
by: Hazem Abdelmotaal, et al.
Published: (2020-01-01)